Search

Search Results
Results 13951 - 13960 of 17241 for Active treatment
  • Drug - 1 Jun 2026
    Consumer Medicine Information (CMI) about Dupixent intended for persons living in Australia.
  • Health - 31 May 2026
    As scientists debate whether food addiction is real, new evidence suggests ultra-processed foods may hijack reward pathways in vulnerable individuals while blurring the line between cravings, eating...
  • News - 29 May 2026
    Experiencing a traumatic event sometimes produces long-lasting biological changes that can lead to an exaggerated fear response to future stressful events, such as what occurs in individuals with...
  • News - 29 May 2026
    Whereas patients in the past were expected to be patient, grateful, passive and docile - many of today's patients are assertive, demanding, impatient and insistent. So, what has happened?
  • White Paper - 29 May 2026
    Improve iPSC culture efficiency and reproducibility with machine learning-enabled passaging control and automated differentiated cell detection.
  • Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Lyrica intended for persons living in Australia.
  • Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Zempreon CFC-Free Inhaler intended for persons living in Australia.
  • Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Asmol CFC-Free Inhaler (with counter) intended for persons living in Australia.
  • Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Prodeinextra intended for persons living in Australia.
  • Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Prodeine intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.